Abstract
Differential Target MultiplexedTM spinal cord stimulation (SCS) is an established therapy that has shown superior back pain relief to traditional SCS.1,2 Derivatives of the DTMTM SCS waveform are being investigated to understand opportunities to further tailor therapy approaches for different patients. A recent feasibility study demonstrated a DTMTM SCS derivative provided significant reduction in energy usage while offering a similar degree of pain relief and therapy satisfaction to patients compared to prior SCS therapy. Data collected to date from an ongoing RCT of the same reduced-energy DTMTM SCS derivative has been used to estimate device longevity for recharge-free devices as well as recharge requirements on rechargeable devices.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
